Campylosel agar 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 BioMerieux 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2016-09-06
  • 사례 출판 날짜
    2016-09-06
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: biomerieux campylosel agar medical device manufacturer, biomerieux, has issued a medical device safety alert concerning its campylosel agar [reference number: 43361; lot number: 1004948090, 1004981930 and 1005023880]. based on a lack of selectivity issue reported on plates of the impacted lots of campylosel agar, the manufacturer initiated a complaint investigation to confirm product performance and determine root cause. while the investigation is still ongoing, the following have been identified: there is growth of a enterobacter cloacae strain isolated in a laboratory on the impacted lots of campylosel agar that could mask the growth of the campylobacter strain. this growth could lead to a misinterpretation of the results and therefore to a false negative result. the growth of this enterobacter cloacae strain on the impacted lots of campylosel agar could be explained by higher mic for aztreonam and cefoperazon antibiotics than usually. according to the manufacturer, immediate corrective action was implemented on 5 aug 2016 at the manufacturing site level to optimize campylosel agar manufacturing conditions by reducing the additive shelf-life when used for the manufacturing of campylosel agar. the users are advised to follow the instructions and implemented the actions as indicated in field safety notice according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 6 september 2016.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: BioMerieux Campylosel agar
  • Manufacturer

Manufacturer